Abstract
Motor excitability is increased in both hemispheres in stroke patients during motor recovery. Pharmacologically controlled changes of cortical excitability might be beneficial for synaptic plasticity and therefore facilitate functional recovery after a brain lesion. In particular, it has been suggested that antidepressant drugs can modulate motor excitability. Several recent reports suggest the possibility of monitoring pharmacological effects on brain excitability through transcranial magnetic stimulation (TMS). The aim of this study was to investigate motor area excitability in patients with stroke after oral administration of citalopram. We conducted a prospective randomised placebo controlled study. Twenty patients with unilateral stroke were included in the study: ten patients treated by antidepressive drug and ten patients with placebo. A selective serotonergic drug (citalopram) or a placebo was administered using a mean dosage of 10 mg/day in combination with physiotherapy. Motor cortex excitability was studied by single and paired transcranial magnetic stimulation. TMS recording was tested before (T1) and 1 month after (T2) beginning drug treatment. Patients treated by the serotonergic drug, compared to patients that received a placebo, showed a significant improvement in neurological status as measured by NIHSS and a decrease of motor excitability over the unaffected hemisphere, while no differences were observed over the affected hemisphere. Our findings suggest that treatment with serotonergic drugs can bring about a significant decrease of the motor cortex excitability in stroke patients with effects on both the affected and unaffected hemispheres associated with a better motor recovery.
References
Andersen G, Vestergaard K, Lauritzen L (1994) Effective treatment of post-stroke depression with the selective serotonin reuptake inhibitor citalopram. Stroke 25:1099–1104
Berthier ML, Hinojosa J, Martin MC, Fernandez I (2003) Open-label study of donezepil in chronic post-stroke aplasia. Neurology 60:1218–1219
Berthier ML, Pujol J, Gironell A, Kulisevsky J, Deus J, Hinojosa J (2003) Beneficial effect of donezepil on sensorimotor function after stroke. Am J Phys Med Rehabil 82:725–729
Bobath B (1970) Adult hemiplegia: evaluation and treatment, 2nd edn. William Heinemann Medical Books, London
Chemerinski E, Robinson RG, Kosier JT (2001) Improved recovery in activities of daily living associated with remission of poststroke depression. Stroke 32:113–117
Chollet F, DiPiero V, Wise RJS, Brooks DJ, Dolan RJ, Frackowiak RSJ (1991) The functional anatomy of motor recovery after stroke in humans: a study with positron emission tomography. Ann Neurol 26:63–71
Cohen LG, Ziemann U, Chen R, Classen J, Hallett M, Gerloff C, Butefisch C (1998) Studies of neuroplasticity with transcranial magnetic stimulation. J Clin Neurophysiol 15:305–324 (review)
Cramer SC, Nelles G, Benson RR, Kaplan JD, Parker RA, Kwong KK et al (1997) A fMRI study of subjects recovered from hemiparetic stroke. Stroke 28:2518–2527
Dam M, Tonin P, De Boni A, Pizzolato G, Casson S, Ermani M (1996) Effects of fluoxetine and maptroline on functional recovery in poststroke hemiplegic patients undergoing rehabilitation therapy. Stroke 27:1211–1214
Gainotti G, Antonucci G, Marra C, Paolucci S (2001) Relation between depression after stroke, antidepressant therapy, and functional recovery. J Neurol Neurosurg Psychiatry 71:258–261
Hamilton M (1960) A rating scale for depression. J Neurol Neurosurg Psychiatry 23:58–62
Kujirai T, Caramia MD, Rothwell JC, Day BL, Thompson PD, Ferbert A et al (1993) Corticocortical inhibition in human motor cortex. J Physiol 471:501–519
Liepert J, Storch P, Fritsch A, Weiller C (2000) Motor cortex disinhibition in acute stroke. Clin Neurophysiol 111:671–676
Lindmark B, Hamrin E (1988) Evaluation of functional capacity after stroke as a basis for active intervention. Presentation of a modified chart for motor capacity assessment and its reliability. Scand J Rehabil Med 3:103–109
Lyden P, Brott T, Tilley B, Welch KMA, Maascha EJ, Ninds TPA (1994) Stroke study group improved reliability of the NIH stroke scale using video training. NINDS TPA Stroke Study Group. Stroke 25:2220–2226
Mahoney FI, Barthel DW (1965) Functional evaluation: the Barthel index. Md State Med J 14:61–85
Manganotti P, Bongiovanni LG, Zanette G, Fiaschi A (1999) Cortical excitability in patients after loading doses of lamotrigine: a brain magnetic stimulation study. Epilepsia 40:316–321
Manganotti P, Bortolomasi M, Zanette G, Pawelzik T, Giacopuzzi M, Fiaschi A (2001) Intravenous clomipramine decreases excitability of human motor cortex. A study with paired magnetic stimulation. J Neurol Sci 184:27–32
Manganotti P, Patuzzo S, Cortese F, Palermo A, Smania N, Fiaschi A (2002) Motor disinhibition in affected and unaffected hemisphere in the early period of recovery after stroke. Clin Neurophysiol 113:936–943
Manganotti P, Acler M, Zanette GP, Smania N, Fiaschi A (2008) Motor cortical disinhibition during early and late recovery after stroke. Neurorehabil Neural Repair 22(4):396–403
Martinsson L, Wahlgren NG, Hardemark HG (2003) Amphetamines for improving recovery after stroke. Cochrane Database Syst Rev (3):CD002090
Mittman T, Luhmann HJ, Schmidt-Kastner R, Eysel UT, Weigel H, Heinemann U (1994) Lesion induced transient suppression of inhibitory function in rat neocortex in vitro. Neuroscience 60:891–906
Paolucci S, Antonucci G, Grasso MG, Morelli D, Troisi E, Coiro S, Ermani M (2001) Post-stroke depression, antidepressant treatment and rehabilitation results: a case–control study. Cerebrovasc Dis 12:264–271
Pariente J, Loubinoux I, Carel C, Albucher JF, Leger A, Manelfe C (2001) Fluoxetine modulates motor performance and cerebral activation of patients recovering from stroke. Ann Neurol 55:454–456
Robol E, Fiaschi A, Manganotti P (2004) Effects of citalopram on the excitability of the human motor cortex: a paired magnetic stimulation study. J Neurol Sci 221:41–46
Rossini PM, Barker AT, Berardelli A, Caramia MD, Caruso G, Cracco RQ et al (1994) Noninvasive electrical and magnetic stimulation of the brain, spinal cord and roots: basic principles and procedures for routine clinical application. Report of an IFCN committee. Electroencephalogr Clin Neurophysiol 91:79–92
Salkind MR (1969) Beck depression inventory in general practice. J R Coll Gen Pract 18:267–271
Schiene K, Bruehl C, Zilles K, Qu M, Hagemann G, Kraemer M, Witte OW (1996) Neuronal hyperexcitability and reduction of GABA receptor expression in the surround of cerebral photothrombosis. J Cereb Blood Flow Metab 16:906–914
Stroemer RP, Kent TA, Hulsebosch CE (1998) Enhanced neocortical neural sprouting, synaptogenesis, and behavioral recovery with d-amphetamine therapy after neocortical infarction in rats. Stroke 29:2381–2393
Talelli P, Greenwood RJ, Rothwwell JC (2006) Arm function after stroke: Neurophysiological correlates and recovery mechanism assessed by transcranial magnetic stimulation. Clin Neurophysiol 117:1641–1659 (review)
Tombari D, Ricciardi MC, Bonaffini N, Pasquini M, Cecconi M, DiPiero V, Lenzi GL (2006) Functional MRI, drugs, and poststroke recovery. Clin Exp Hypertens 28:301–307
Ward NS, Brown MM, Thompson AJ, Frackowiak RSJ (2003) Neural correlates of outcome after stroke: a cross-sectional fMRI study. Brain 126:1430–1448
Ward NS, Brown MM, Thompson AJ, Frackowiak RSJ (2004) The influence of time after stroke on brain activations during a motor task. Ann Neurol 6:829–834
Werhahn KJ, Forderreuther S, Straube A (1998) Effects of the serotonin1B/1D receptor agonist zolmitriptan on motor cortical excitability in humans. Neurology 51:896–898
Ziemann U, Rothwell JC, Ridding MC (1996) Interaction between intracortical inhibition and facilitation in human motor cortex. J Physiol 496:873–881
Ziemann U (2004) TMS and drugs. Clin Neurophysiol 115:1717–1729 (review)
Author information
Authors and Affiliations
Corresponding author
Additional information
M. Acler and P. Manganotti equally participated to the work.
Rights and permissions
About this article
Cite this article
Acler, M., Robol, E., Fiaschi, A. et al. A double blind placebo RCT to investigate the effects of serotonergic modulation on brain excitability and motor recovery in stroke patients. J Neurol 256, 1152–1158 (2009). https://doi.org/10.1007/s00415-009-5093-7
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00415-009-5093-7